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Free Epsilon Amino Groups and 5-
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The free e-amino groups and 5-hydroxymethylfurfural (5-HMF) contents were determined in soluble
and insoluble proteins of clear human lenses and diabetic and nondiabetic senile cataractous lenses. The
free e-amino group content of soluble proteins in diabetic cataracts was decreased by 37% (P < 0.01),
whereas in nondiabetic senile cataracts it did not differ from that of clear lenses. The free e-amino group
content of insoluble proteins both in diabetic and nondiabetic cataracts was decreased significantly (P
< 0.001, P < 0.015, respectively). The 5-HMF content of soluble proteins in diabetic cataracts was
increased by 52% (P < 0.001), whereas in nondiabetic cataracts it did not change from that of clear
lenses. The 5-HMF content of insoluble proteins in diabetic as well as in nondiabetic cataracts was
increased significantly as compared to that of clear lens (P < 0.001, P < 0.001, respectively). The
soluble protein of diabetic and nondiabetic cataracts was decreased with an increase in the insoluble
protein content. These results suggest that nonenzymatic glycosylation plays a role in the conformational
change of lens proteins in both diabetic and nondiabetic cataracts. Invest Ophthalmol Vis Sci 27:98-
102,1986
Nonenzymatic glycosylation is a condensation re-
action between reducing sugars and free amino groups.
Following the demonstration that hemoglobin under-
goes post-translational nonenzymatic glycosylation in
vivo,1 a variety of proteins such as rat albumin, human
collagen, and basement membrane proteins were
shown to be subjected to this reaction under physio-
logical conditions.2'4 It was also shown that the rate of
nonenyzmatic glycosylation is influenced by a number
of factors such as the availability of reducing sugar,
life-span of individual proteins, pH, temperature, etc.5'6
Nonenzymatic glycosylation was also shown to be in-
volved in pathogenic complications of diabetes melli-
tus, like browning of collagen and collagen-rich tissues
with increasing stiffness.7'8 It was further suggested that
nonenzymatic glycosylation plays a role in experimen-
tal sugar cataractogenesis.910 However, studies from
different laboratories could not support the hypothesis
that glycosylation is involved in cataract formation.""13
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Furthermore, the recent reports by Garcia-Castineiras
and Miranda-Rivera14 and Truscott15 on the contents
of free amino groups in cataractous lenses stand con-
tradictory to each other. Because of these discrepancies
in the conclusions, we have determined the glycosylated
product, 5-HMF, and free e-amino groups in soluble
and insoluble proteins of extracapsular diabetic and
nondiabetic human cataractous lenses. The results are
reported in the present communication.
Materials and Methods
Trinitrobenzenesulfonic acid (TNBS), 2-thiobarbi-
turic acid, sodium borohydride were purchased from
Sigma Chemical Company; St. Louis, MO. All other
reagents used were of analytical grade.
Human cataractous lenses which were removed by
intracapsular cryosurgery were procured from the New
York Hospital, New York. The normal human lenses
were supplied by the Eye Bank for Sight Restoration,
Inc., New York. The cataractous lenses were classified
according to Cicchetti et al.16 The capsule of the normal
and cataractous lenses was removed. The decapsulated
lenses were homogenized individually in double dis-
tilled water using Potter-Elvehjem homogenizer and
centrifuged for 1 hr at 10000 X g in a Sorvall RC-2B
refrigerated centrifuge at 0°C. The pellet was washed
with double distilled water and centrifuged again as
above. The supernatants were combined. The super-
natant and the pellets were referred to as soluble and
98
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insoluble proteins, respectively. The supernatants and
the pellets (suspended homogeneously in 2.0 ml of
double distilled water) were dialysed (M.W. cut-off
3,500) against water for 48 hr and lyophilized. The
lyophilized material was used for the determination of
free e-amino groups, 5-HMF and protein.
Free e-amino Groups
The free e-amino groups were measured according
to the procedure of Kakade and Liener17 as described
by Eklund.18 To 1.0 ml of the sample containing 1 mg
of protein, 1.0 ml of 4% (W/V) NaHCO3 (pH 8.5) and*
1.0 ml of 0.1% aqueous TNBS solutions were added
and incubated for 2 hr at 40°C. After incubation, 4.5
ml of cone HC1 was added and hydrolyzed for 90 min
at 110°C. The hydrolysates were cooled to room tem-
perature and centrifuged at 3000 rpm for 10 min. The
supernatants were extracted twice with 10 ml of ether
in order to remove a-TNP amino complexes. The
aqueous solution was kept in hot water till residual
ether evaporated. The optical densities of these aqueous
solutions were measured at 346 nm on a Gilford spec-
trophotometer against a blank prepared in the same
way as that of the test except that the HC1 was added
prior to TNBS addition. In the determination of free
e-amino groups in insoluble proteins, 1.0 mg of the
latter was suspended homogeneously in 1.0 ml of 4%
NaHCOa and submitted to the rest of the procedure
as mentioned above. The free e-amino group content
in the samples was calculated using the molar extinc-
tion coefficient value of 1.46 X 104 17 and the values
are expressed as /umol per mg protein.
5-hydroxymethylfurfural
The 5-HMF content in soluble and insoluble pro-
teins was determined by the method of Dolhofer and
Wieland.19 Four milligrams of protein dissolved in 4.0
ml of buffer (soluble protein was dissolved in 0.1 M
sodium phosphate buffer, pH 7.0 and insoluble protein
was suspended homogeneously in 0.05 M Tris-HCl
buffer containing 0.1 M KC1 and 7 M urea, pH 8.5)
and divided into 2 equal halves (2.0 ml each). The first
half was treated with 19 mg of sodium borohydride for
1 hr at room temperature. Trace amounts of octanol-
1 were added to prevent frothing. The second half
without sodium borohydride treatment served as a
control. The test and the control samples were dialyzed
for 18 hr at 4°C against 4 litres of 0.9% NaCl with 2
changes. After dialysis, the volumes of the test and
control samples were adjusted to 3.0 ml with 0.9% NaCl
(the protein content in the test and control is same)
and incubated with 0.45 ml of glacial acetic acid for
24 hr at 100°C. Following hydrolysis, 0.75 ml of 3.0
M TCA was added and centrifuged at 3000 rpm for
30 min. Then, 1.0 ml of the supernatant was incubated
with 0.5 ml of 50 mM 2-thiobarbituric acid for 30 min
at 40°C. After completion of the incubation, the so-
lutions were cooled to room temperature, and the op-
tical densities were measured at 443 nm. The amount
of 5-HMF in the samples was calculated using its molar
extinction coefficient value of 4 X 104, and the values
are expressed as nmol per mg protein.
The protein content was determined by the method
of Lowry et al20 using bovine serum albumin as a stan-
dard.
Results
The soluble, insoluble, and total protein and free e-
amino groups and 5-HMF contents of clear human
lenses and diabetic and nondiabetic senile cataracts are
shown in Tables 1 and 2. The soluble protein content
of types B, C, and D of nondiabetic senile cataracts
was decreased by 31.66, 33.15 and 55.99% respectively
(P < 0.05, P < 0.05, P < 0.01, respectively), and in
diabetic cataracts it was decreased by 32.58% (P < 0.05)
as compared to the values of the age-matched clear
lenses. On the other hand, the insoluble protein content
of B, C, and D types of nondiabetic senile cataracts
was increased by 82.72, 128.07, and 224.56% respec-
tively (P < 0.05, P < 0.001, P < 0.001, respectively),
and in diabetic cataracts it was increased by 50.61%
(P < 0.05, Table 1). However, the total protein content
in both diabetic and nondiabetic senile cataracts did
not differ significantly from that of clear lenses (Table
1). The ratio of insoluble to soluble protein was in-
creased in all types of cataracts, being the highest in
type D (Table 1).
Free e-amino group content of soluble proteins of
nondiabetic senile cataracts did not differ from that of
clear lenses, whereas in diabetic cataracts it was de-
creased by 37% (P < 0.01, Table 2). The free e-amino
groups of insoluble proteins in B, C, and D types of
senile nondiabetic cataracts were decreased by 31.79,
30.43, and 23.64% respectively (P < 0.05, P < 0.05,
P < 0.05, respectively). The free e-amino groups of in-
soluble proteins of diabetic cataracts were decreased
by 48.91% (P < 0.001, Table 2) as compared to the
values of clear lenses. The 5-HMF content of soluble
proteins of all the 4 types of senile nondiabetic cataracts
did not change from that of clear lenses, whereas in
diabetic cataracts it was increased by 52% (P < 0.001,
Table 2). The 5-HMF content of insoluble proteins of
types B, C, and D senile nondiabetic cataracts was in-
creased by 25.17, 27.24, and 33.10% respectively
(P < 0.05 for type C and P < 0.01 for type D), and in
diabetic cataracts it was increased by 81.72% (P
< 0.001, Table 2).
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Table 1. Soluble and insoluble protein contents in clear human lenses and senile and diabetic cataracts
Clear human lens
(64-72 yr)*
Cataractf
Type A (60-75 yr)
% change
P<
Type B (66-75 yrs)
% change
P<
Type C (62-68 yrs)
% change
P<
Type D (60-76 yrs)
% change
P<
Diabetic cataract
(52-69 yrs)
% change
P<
Soluble
35.6 ± 1.16(5)
28.33 ± 1.85(6)
-20.42
NS
24.33 ±2.17 (6)
-31.66
0.05
23.80 ±2.13 (5)
-33.15
0.05
14.6 ± 1.25(5)
-58.99
0.01
24.0 ±2.63(6)
-32.58
0.05
Protein (mg/lens)
Insoluble
11.4 ± 1.08(5)
12.83 ± 1.38(6)
+ 12.54
NS
20.83 ± 0.80 (6)
+82.72
0.05
26.0 ±2.39(5)
+ 128.07
0.001
37.0 ± 1.38(5)
+224.56
0.001
17.17 ±2.22 (6)
+50.61
0.05
Total
47.0 ± 1.73(5)
41.17 ±2.64 (6)
-12.40
NS
45.17 ±2.84 (6)
-3.89
NS
49.8 ±4.38(5)
+5.96
NS
51.6 ± 1.75(5)
+9.79
NS
41.17 ±3.46 (6)
-12.40
NS
Ratio of
insoluble/soluble
0.32 ±0.03(5)
0.457 ± 0.043 (6)
+43.75
NS
0.880 ± 0.058 (6)
+ 175.00
0.001
1.01 ±0.054(5)
+243.75
0.001
2.61 ±0.259(5)
+715.63
0.001
0.77 ±0.14(6)
+ 140.63
0.001
* No significant variation was measured in the protein content within any
one category of cataractous lenses with respect to the age group studied.
t Cataract Type A = yellow with moderate opacities; B = light brown with
moderate opacities; C = brown with intense opacities; D = dark brown with
intense to total opacities; diabetic cataracts analyzed in this study are light
brown in color with moderate to intense opacities.
Parentheses indicate number of lenses analyzed.
Table 2. Free epsilon amino groups and 5-hydroxymethylfurfural contents in clear human
lenses and in senile and diabetic cataracts
Clear human lens
(64-72 yr)$
Cataract§
Type A (60-75 yr)
% change
P<
Type B (66-75 yr)
% change
P<
Type C (62-68 yr)
% change
P<
Type D (60-76 yr)
% change
P<
Diabetic cataract
(52-69 yr)
% change
P<
Free epsilon amino groups*
Soluble
0.140 ±0.010 (5)
0.138 ±0.010 (6)
-1.43
NS
0.139 ±0.012(6)
-0.71
NS
0.130 ±0.034 (5)
-7.14
NS
0.139 ±0.012 (5)
-0.71
NS
0.088 ± 0.004 (6)
-37.14
0.01
Insoluble
0.368 ± 0.028 (5)
0.372 ± 0.026 (6)
+ 1.08
NS
0.251 ±0.027 (6)
-31.79
0.05
0.256 ±0.017 (5)
-30.43
0.05
0.281 ±0.016(5)
-23.64
0.05
0.188 ±0.006(6)
-48.91
0.001
5-hydroxymethyl furfural\
Soluble
0.233 ±0.014 (5)
0.254 ±0.013 (6)
+9.01
NS
0.254 ± 0.009 (6)
+9.01
NS
0.289 ±0.017 (5)
+24.03
NS
0.229 ± 0.006 (5)
-1.70
NS
0.353 ± 0.005 (6)
+51.50
0.001
Insoluble
0.290 ± 0.020 (5)
0.342 ±0.013 (6)
+ 17.90
NS
0.363 ± 0.020 (6)
+25.17
NS
0.369 ± 0.026 (5)
+27.34
0.05
0.386 ± 0.028 (5)
+33.10
0.01
0.527 ±0.011(6)
+81.72
0.001
* /zmol/mg protein
t nanomol/mg protein
% No significant variation was measured in the free f-amino group and 5-
HMF contents within any one category of cataractous lenses with respect to
the age groups studied.
§ Cataract Type A = yellow with moderate opacities; B = light brown with
moderate opacities; C = brown with intense opacities; D = dark brown with
intense to total opacities; diabetic cataracts analyzed in this study are light
brown in color with moderate to intense opacities.
NS = statistically not significant.
Parentheses indicate number of lenses analyzed.
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Discussion
Dische and Zil21 first reported increased disulfides
in human cataracts, and since then a number of in-
vestigators confirmed the same in human senile and
experimental animal cataracts.22"24 These disulfide
bonds are thought to be responsible for the formation
of high molecular weight aggregates in cataracts.22
Monnier et al10 demonstrated that lens crystallines
upon glycosylation become more susceptible to oxi-
dation leading to the formation of disulfide linked high
molecular weight aggregates, which could explain cat-
aractogenesis in diabetic condition. Ansari et al12 have
reported increased glycosylation of lens proteins in hu-
man cataracts; however, in these studies no correlation
was found between glycosylation and sulfhydryl oxi-
dation of lens proteins. On the other hand, increased
glycosylation of aged bovine lens a-crystallins, partic-
ularly high molecular weight a-crystallin (HMWa), was
reported by Chiou et al.13 Thus, increasing attention
is being paid to nonenzymatic glycosylation of proteins,
as this process was shown to be involved in many
pathogenic complications of diabetes mellitus such as
browning of collagen and collagen-rich tissues with in-
creasing stiffness.7 It was further shown that the long-
lived proteins like collagen, lens crystallins, basement
membrane proteins, and basic nerve myelin protein
are more susceptible to nonenzymatic glycosyla-
tion.25'26 As nonenzymatic glycosylation is a conden-
sation reaction between free amino groups and reduc-
ing sugars, attempts were made by Garcia-Castineiras
and Miranda-Rivera14 and Truscott15 on the deter-
mination of free amino groups in cataracts. However,
their reports on free amino groups in cataracts are con-
tradictory to each other. Our studies on the determi-
nation of the nonenzymatic glycosylated product, 5-
HMF, revealed a significant increase in its content in
soluble and insoluble proteins of diabetic cataracts and
in insoluble proteins of nondiabetic cataracts. The de-
crease in the free e-amino groups in soluble and insol-
uble proteins of diabetic cataracts and in insoluble pro-
teins of nondiabetic cataracts further supports the oc-
currence of nonenzymatic glycosylation in cataracts.
Recently Garlick et al27 have reported twofold increase
in glycosylation in soluble and insoluble proteins of
diabetic lenses. Kasai et al28 have demonstrated the
nonenzymatic glycosylation of lens soluble proteins by
incubating the proteins from diabetic and nondiabetic
cataracts with glucose in vitro, and the extent of gly-
cosylation was found more with proteins of the former
type of cataracts. Mandel et al29 reported an increased
glycosylation of lens capsule in diabetics as compared
to the nondiabetics. From our results it is evident that
the extent of nonenzymatic glycosylation is more
(twofold higher) in diabetic cataracts as compared with
clear lens values, indicating that the glycosylation re-
action is proportional to the glucose level. Our results
on 5-HMF in soluble and insoluble proteins of diabetic
cataracts agree with the results of Garlick et al27 with
respect to the twofold increase. Recently, Liang and
Chylack30 by circular dichroism studies have shown
a change in the tertiary structure of a-crystallin upon
glycosylation. The increased nonenzymatic glycosy-
lation of human skin collagen caused more stiffness
and resistance to enzymatic hydrolysis.7 Based on all
these findings, it may be mentioned that increased gly-
cosylation leads to the conformational changes in lens
crystallins, which further results in the opacification of
the lens. It is interesting to note that the decrease in
the free e-amino groups in soluble and insoluble pro-
teins of diabetic cataracts and insoluble proteins of
nondiabetic cataracts could not be explained by non-
enzymatic glycosylation reaction alone, since the rise
in 5-HMF content was several hundredfold less than
the decrease in free e-amino groups. Hence, it is also
tempting to speculate the involvement of other mech-
anisms such as carbamylation31 and isopeptide bond
formation32 besides nonenzymatic glycosylation in
cataracts, which could probably explain the decrease
in free e-amino groups. Or otherwise, it could be pos-
sible that the glycosylation reaction reached beyond
the reducible Maillard products in cataracts, in which
case the increase in 5-HMF would not be proportional
to the decrease in free e-amino groups.
The decrease in soluble protein contents of both di-
abetic and nondiabetic cataracts could be explained by
an increase in insoluble protein content, as the total
protein content of cataracts did not change significantly
from that of age-matched clear human lenses. Further
studies on the susceptibility of lens proteins, particu-
larly individual crystallins to various chemical modi-
fications like carbamylation and glycosylation, are of
importance in order to understand the role of post-
translational modifications of crystallins in cataracto-
genesis.
Key words: human clear lens, human diabetic and nondi-
abetic senile cataracts, nonenzymatic glycosylation, epsilon
amino groups, 5-hydroxymethylfurfural
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